PL364054A1 - Homogenised product for implants and microparticles - Google Patents

Homogenised product for implants and microparticles

Info

Publication number
PL364054A1
PL364054A1 PL02364054A PL36405402A PL364054A1 PL 364054 A1 PL364054 A1 PL 364054A1 PL 02364054 A PL02364054 A PL 02364054A PL 36405402 A PL36405402 A PL 36405402A PL 364054 A1 PL364054 A1 PL 364054A1
Authority
PL
Poland
Prior art keywords
microparticles
implants
homogenised product
homogenised
product
Prior art date
Application number
PL02364054A
Other languages
Polish (pl)
Inventor
Gregor Schütz
Brigitte Freudensprung
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26009392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL364054(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE2001125509 external-priority patent/DE10125509A1/en
Priority claimed from DE2002108382 external-priority patent/DE10208382A1/en
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of PL364054A1 publication Critical patent/PL364054A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

The invention relates to a method for the solvent-free preparation of a homogenizate, especially for implants or microparticles, wherein one or more polymers and one or more active constituents, as raw materials, are homogenized together below the glass transition temperature of the polymer(s) and, when homogenization is complete, brought to room temperature.
PL02364054A 2001-05-23 2002-05-23 Homogenised product for implants and microparticles PL364054A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2001125509 DE10125509A1 (en) 2001-05-23 2001-05-23 Homogenate production, especially for use in implants and/or microparticles, by homogenizing mixture of active agent, e.g. hormone, and polymer below the glass transition temperature in the absence of solvent
DE2002108382 DE10208382A1 (en) 2002-02-27 2002-02-27 Homogenate production, especially for use in implants and/or microparticles, by homogenizing mixture of active agent, e.g. hormone, and polymer below the glass transition temperature in the absence of solvent
PCT/EP2002/005680 WO2002094226A1 (en) 2001-05-23 2002-05-23 Homogenised product for implants and microparticles

Publications (1)

Publication Number Publication Date
PL364054A1 true PL364054A1 (en) 2004-12-13

Family

ID=26009392

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02364054A PL364054A1 (en) 2001-05-23 2002-05-23 Homogenised product for implants and microparticles

Country Status (16)

Country Link
US (1) US8501056B2 (en)
EP (1) EP1392248B1 (en)
JP (1) JP4346909B2 (en)
AT (1) ATE369122T1 (en)
BR (1) BR0209914A (en)
CA (1) CA2449502C (en)
CY (1) CY1106944T1 (en)
CZ (1) CZ20033160A3 (en)
DE (1) DE50210646D1 (en)
DK (1) DK1392248T3 (en)
ES (1) ES2290294T3 (en)
NO (1) NO20035179D0 (en)
PL (1) PL364054A1 (en)
PT (1) PT1392248E (en)
SK (1) SK14182003A3 (en)
WO (1) WO2002094226A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK14182003A3 (en) 2001-05-23 2004-05-04 Hexal Ag Homogenised product for implants and microparticles
FR2879074B1 (en) * 2004-12-15 2007-08-03 Adisseo France Sas Soc Par Act PELLETS OF ACTIVE HYDROPHILIC PRINCIPLE
FR2879075B1 (en) * 2004-12-15 2007-01-19 Adisseo France Sas Soc Par Act PROCESS FOR PREPARING EXTRUSION-ACTIVE HYDROPHILIC ACTIVE INGREDIENT PELLETS
CN101095941B (en) * 2006-06-29 2011-04-20 北京博恩特药业有限公司 Novel use of leuprorelin acetate in the preventing and treating of osteoporosis
US20100291214A1 (en) * 2008-12-23 2010-11-18 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
WO2010151746A2 (en) * 2009-06-26 2010-12-29 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
DE102011114864A1 (en) 2011-10-05 2013-04-11 Acino Ag Process for producing a homogeneous powder mixture and method for producing an implant and implant
CN104023704B (en) * 2011-10-31 2016-08-17 花王株式会社 Cosmetics
DE102013011399A1 (en) 2012-07-31 2014-02-06 Amw Gmbh Rod-shaped biodegradable implant useful for maintenance therapy in schizophrenia in patients comprises risperidone
US20170319749A1 (en) * 2014-11-14 2017-11-09 Nanyang Technological University Bioresorbable-magnesium composite
USD782771S1 (en) 2015-04-03 2017-03-28 Geo Plastics Tight head drum
EP3492070A1 (en) 2017-11-30 2019-06-05 BIT Pharma GmbH Process and device for preparing a solid dispersion
USD938128S1 (en) 2020-01-06 2021-12-07 Geo Plastics Nestable drum
USD1001413S1 (en) 2020-06-30 2023-10-10 Geo Plastics Nestable drum

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992350A (en) * 1972-05-04 1976-11-16 Produits Chimiques Ugine Kuhlmann Process of mixing fillers with polytetrafluorethylene and tetrafluorethylene copolymers
US4016345A (en) 1972-12-22 1977-04-05 E. I. Du Pont De Nemours And Company Process for polymerizing tetrafluoroethylene in aqueous dispersion
FR2418067A1 (en) 1978-02-22 1979-09-21 Omya Sa Adding solids, liquids or pastes to polymers - at room temp. after low-temp. grinding
EP0300241B1 (en) * 1987-07-10 1991-09-25 Karl Reinhard Zeiss Process for producing and processing reactive plastic mixtures
US4917834A (en) * 1988-11-16 1990-04-17 General Technology Applications, Inc. Method for forming homogeneous blends of particulate materials
CH679207A5 (en) * 1989-07-28 1992-01-15 Debiopharm Sa
US5439688A (en) * 1989-07-28 1995-08-08 Debio Recherche Pharmaceutique S.A. Process for preparing a pharmaceutical composition
US5843347A (en) * 1993-03-23 1998-12-01 Laboratoire L. Lafon Extrusion and freeze-drying method for preparing particles containing an active ingredient
US5456917A (en) 1993-04-12 1995-10-10 Cambridge Scientific, Inc. Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
DE19545327C2 (en) * 1995-12-05 2001-04-19 Fraunhofer Ges Forschung Process for the preparation of hydrophobized resorbable polyesters and their use
US5817343A (en) * 1996-05-14 1998-10-06 Alkermes, Inc. Method for fabricating polymer-based controlled-release devices
US5945128A (en) 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
US6177609B1 (en) * 1997-03-10 2001-01-23 Meadox Medicals, Inc. Self-aggregating protein compositions and use as sealants
KR20010023256A (en) * 1997-08-27 2001-03-26 헥살 아게 New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
SK285812B6 (en) 1998-12-16 2007-08-02 Aventis Pharmaceuticals Inc. Pharmaceutical composition comprising serotonin receptor antagonist and method for the production thereof
US6455526B1 (en) * 1998-12-16 2002-09-24 Aventis Pharmaceuticals, Inc. Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same
US6291013B1 (en) 1999-05-03 2001-09-18 Southern Biosystems, Inc. Emulsion-based processes for making microparticles
SK14182003A3 (en) 2001-05-23 2004-05-04 Hexal Ag Homogenised product for implants and microparticles
US6712850B2 (en) * 2001-11-30 2004-03-30 Ethicon, Inc. Porous tissue scaffolds for the repair and regeneration of dermal tissue
US6894088B2 (en) * 2003-03-24 2005-05-17 Baker Hughes Incorporated Process for homogenizing polyolefin drag reducing agents

Also Published As

Publication number Publication date
WO2002094226A1 (en) 2002-11-28
NO20035179D0 (en) 2003-11-21
ATE369122T1 (en) 2007-08-15
US20040173923A1 (en) 2004-09-09
JP2004530696A (en) 2004-10-07
BR0209914A (en) 2004-04-06
ES2290294T3 (en) 2008-02-16
DE50210646D1 (en) 2007-09-20
DK1392248T3 (en) 2007-11-12
CA2449502C (en) 2010-10-12
JP4346909B2 (en) 2009-10-21
EP1392248B1 (en) 2007-08-08
CA2449502A1 (en) 2002-11-28
CZ20033160A3 (en) 2004-03-17
SK14182003A3 (en) 2004-05-04
EP1392248A1 (en) 2004-03-03
CY1106944T1 (en) 2012-09-26
PT1392248E (en) 2007-10-11
US8501056B2 (en) 2013-08-06

Similar Documents

Publication Publication Date Title
CY1106944T1 (en) METHOD FOR PRODUCTION OF INFANTS THROUGH PRODUCTION - WITHOUT SOLVENTS - A HOMOGENIFICATION PRODUCT
DE60011243D1 (en) METHOD FOR THE PRODUCTION OF UHMWPE DOPED WITH ANTIOXIDANT AND IMPLANT PRODUCED THEREOF
AU3155700A (en) New biomaterials
AU2002363933A1 (en) Nanogel networks including polyion polymer fragments and biological agent compositions thereof
HK1056332A1 (en) Controlled release composition comprising lactic acid polymer, and method of producing the same
WO2004045464A3 (en) Medical devices
WO2004011611A3 (en) Taci antibodies and uses thereof
WO2002096272A3 (en) Absorbable implantable vaso-occlusive member
AU2002251725A1 (en) Compositions and methods for biomedical applications
AU2003281621A8 (en) Modified calcium carbonate, polymer composition containing the same and process for producing them
AU2003297199A1 (en) Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
TR200003559A2 (en) Hydrocolloid confectionery product
ATE357469T1 (en) STERILIZING POLYMERS AND THEIR PRODUCTION AND USE
AU2003251236A1 (en) Polyamide composition, process of preparation and use for making moulded articles
AU2003236817A1 (en) Plant extracts
EP1051920A3 (en) Process for producing sesame products
EP1757619A3 (en) Osteoprotegerin in milk
AU2002953568A0 (en) Novel chemical composition, method of making same, and products made therefrom
WO2002069944A3 (en) Novel medicament compositions based on anticholinergics and on nk1 receptor antagonists
AU3192299A (en) Improved implantable biomaterials, compositions and methods for their preparation and uses thereof
AU2002251788A1 (en) Novel compounds and uses thereof
DE50205438D1 (en) USE OF BUPRENORPHINE FOR THE THERAPY OF HARNESS INCONTINENCE
WO2002040963A3 (en) Biologically active composites and methods for their production and use
AU2910800A (en) Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
AU2002314215A1 (en) Enzymatic method of producing 4-0-beta-D galactopyranosyl-D-xylose, 4-0-beta-D-galactopyranosyl-D-xylose obtained using said method, compositions containing same and the use thereof in evaluating intestinal lactase

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)